HALO logo
halo search icon
Rakovina Therapeutics Inc

CA$0.13

Price Change Indicator
0.015 (13.04%)
Rakovina Therapeutics Inc
RKV · TSX

Rakovina Therapeutics Inc

Start Trading RKV for Free

CA$0.13

Price Arrow0.015 (13.04%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Rakovina Therapeutics Inc Overview

RKV Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About RKV

icon

Website

Rakovina Therapeutics Inc

icon

Telephone

1.406.613.1453

icon

Address

Suite 720, 999 West Broadway, Vancouver, BC V5Z 1K5

Description

Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.

RKV Price Chart

Key Stats

Market Cap

CA$2.43M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.09 - 0.84

Trade Value (12mth)

US$2,732.00

1 week

-7.14%

1 month

18.18%

YTD

30%

1 year

-76.36%

All time high

3.95

Key Fundamentals

EPS 3 yr Growth

20.00%

EBITDA Margin

0.00%

Operating Cashflow

-$6m

Free Cash Flow Return

-209.00%

ROIC

-306.50%

Interest Coverage

-19.10

Quick Ratio

0.30

Other Data

Shares Outstanding (Fully Diluted)

21m

HALO Sector

Other Finance

Next Company Report Date

23-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

CAD

Short Sell (% of issue)

0.00

RKV Fundamentals

Per Share Records

Historical data

Forecast data

CAD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.37-0.49-0.48locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.37-0.49-0.48locklocklock
Growth
 %locklocklocklock6.4-31.92.8locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Rakovina Therapeutics Inc (RKV:TSX)?
Halo FAQ
The current share price of Rakovina Therapeutics Inc (RKV:TSX) is CAD$0.13.
What is the 52-week high share price for Rakovina Therapeutics Inc (RKV:TSX)?
Halo FAQ
The 52-week high share price for Rakovina Therapeutics Inc (RKV:TSX) is CAD$0.84.
What is the 52-week low share price for Rakovina Therapeutics Inc (RKV:TSX)?
Halo FAQ
The 52-week low share price for Rakovina Therapeutics Inc (RKV:TSX) is CAD$0.09.
What is the dividend yield for Rakovina Therapeutics Inc (RKV:TSX)?
Halo FAQ
Rakovina Therapeutics Inc (RKV:TSX) does not pay a dividend.
What was Rakovina Therapeutics Inc (RKV:TSX) last dividend payment?
Halo FAQ
Rakovina Therapeutics Inc (RKV:TSX) does not pay a dividend.
What is the franking level for Rakovina Therapeutics Inc (RKV:TSX)?
Halo FAQ
Rakovina Therapeutics Inc (RKV:TSX) has a franking level of 0.00%.
In which sector is Rakovina Therapeutics Inc (RKV:TSX) classified?
Halo FAQ
Rakovina Therapeutics Inc (RKV:TSX) is classified in the Other Finance.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial